| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes U Ozcan, Q Cao, E Yilmaz, AH Lee, NN Iwakoshi, E Ozdelen, G Tuncman, ... Science 306 (5695), 457-461, 2004 | 4655 | 2004 |
| Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes U Ozcan, E Yilmaz, L Ozcan, M Furuhashi, E Vaillancourt, RO Smith, ... Science 313 (5790), 1137-1140, 2006 | 2853 | 2006 |
| Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis U Ozcan, L Ozcan, E Yilmaz, K Düvel, M Sahin, BD Manning, ... Molecular cell 29 (5), 541-551, 2008 | 507 | 2008 |
| The proximal tibiofibular joint: an anatomic study M Bozkurt, E Yilmaz, D Atlihan, I Tekdemir, H Havitçiogglu, I Günal Clinical Orthopaedics and Related Research® 406 (1), 136-140, 2003 | 135 | 2003 |
| Frequency of mtDNA A1555G and A7445G mutations among children with prelingual deafness in Turkey M Tekin, T Duman, G Boğoçlu, A Incesulu, E Comak, S Fitoz, E Yılmaz, ... European journal of pediatrics 162, 154-158, 2003 | 86 | 2003 |
| Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 GA N Akar, E Yilmaz, E Akar, F Avcu, A Yalcin, Ş Cin Thrombosis research 97 (4), 227-230, 2000 | 84 | 2000 |
| Endoplasmic reticulum stress and obesity E Yilmaz Obesity and lipotoxicity, 261-276, 2017 | 81 | 2017 |
| Untargeted multi-omic analysis of colorectal cancer-specific exosomes reveals joint pathways of colorectal cancer in both clinical samples and cell culture CC Eylem, M Yilmaz, B Derkus, E Nemutlu, CB Camci, E Yilmaz, ... Cancer letters 469, 186-194, 2020 | 71 | 2020 |
| The role of prothrombotic mutations in patients with Buerger's disease F Avcu, E Akar, U Demirkiliç, E Yilmaz, N Akar, A Yalçin Thrombosis research 100 (3), 143-147, 2000 | 62 | 2000 |
| The effects of Ankaferd Blood Stopper on transcription factors in HUVEC and the erythrocyte protein profile. E Yılmaz, Ş Güleç, D Torun, İC Haznedaroğlu, N Akar Turkish Journal of Hematology, 2011 | 52 | 2011 |
| Familial Mediterranean fever gene (MEFV) mutations in patients with rheumatic heart disease E Tutar, N Akar, S Atalay, E Yilmaz, E Akar, F Yalcinkaya Heart 87 (6), 568-569, 2002 | 48 | 2002 |
| Factor V (His 1299 Arg) in Turkish patients with venous thromboembolism N Akar, E Akar, E Yilmaz American Journal of Hematology 63 (2), 102-103, 2000 | 45 | 2000 |
| Plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation N Akar, E Akar, E Yilmaz, G Deda Journal of Child Neurology 16 (4), 294-295, 2001 | 42 | 2001 |
| Factor V (His 1299 Arg) in young Turkish patients with cerebral infarct N Akar, E Yilmaz, E Akar, G Deda, T Sipahi Pathophysiology of Haemostasis and Thrombosis 30 (3), 118-122, 2000 | 39 | 2000 |
| Bone mineral density reference values in the normal female and male population of Izmir, Turkey M Manisalı, D Özaksoy, E Yilmaz, Ö Şenocak, H Tatari, Ö Baran, ... European radiology 13, 157-162, 2003 | 35 | 2003 |
| Dual diverse dynamic reversible actions of Ankaferd on EPCR and PAI-1 inside vascular endothelial cells with and without LPS A Karabıyık, E Yılmaz, Ş Güleç, İ Haznedaroğlu, N Akar | 32* | 2012 |
| Evaluation of potential salivary acetaldehyde production from ethanol in oral cancer patients and healthy subjects H Kocaelli, A Apaydin, B Aydil, M Ayhan, A Karadeniz, S Ozel, E Yılmaz, ... Hippokratia 18 (3), 269, 2014 | 31 | 2014 |
| Liken sekonder bileşiklerinin farklı insan kanser hücre tipleri üzerine antikanserojenik etkisi S Özenoğlu, G Aydoğdu, AB Dinçsoy, AA Taghidizaj, K Derici, E Yılmaz, ... Türk Hijyen ve Deneysel Biyoloji Dergisi 70 (4), 215-26, 2013 | 31 | 2013 |
| Vitamin D and melatonin protect the cell’s viability and ameliorate the CCl4 induced cytotoxicity in HepG2 and Hep3B hepatoma cell lines D Özerkan, N Özsoy, E Yılmaz Cytotechnology 67, 995-1002, 2015 | 27 | 2015 |
| Reversible protease-activated receptor 1 downregulation mediated by Ankaferd blood stopper inducible with lipopolysaccharides inside the human umbilical vein endothelial cells A Karabıyık, S Güleç, E Yilmaz, I Haznedaroglu, N Akar Clinical and Applied Thrombosis/Hemostasis 17 (6), E165-E170, 2011 | 27 | 2011 |
